Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy.

Shiota M, Fujimoto N, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Front Oncol. 2018 Dec 18;8:635. doi: 10.3389/fonc.2018.00635. eCollection 2018.

2.

Utility of a 3-Dimensional Printed Model to Simulate Transcatheter Aortic Valve Implantation in a Patient With an Intramural Hematoma and a Penetrating Atherosclerotic Ulcer in the Distal Aortic Arch.

Yaku H, Saito N, Imai M, Sakamoto K, Toyota T, Watanabe H, Taniguchi T, Shiomi H, Imada K, Seo H, Yamazaki K, Kimura T.

Circ Cardiovasc Interv. 2018 Dec;11(12):e006925. doi: 10.1161/CIRCINTERVENTIONS.118.006925. No abstract available.

PMID:
30562089
3.

Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer.

Shiota M, Kashiwagi E, Murakami T, Takeuchi A, Imada K, Inokuchi J, Tatsugami K, Eto M.

Urol Oncol. 2018 Nov 13. pii: S1078-1439(18)30404-6. doi: 10.1016/j.urolonc.2018.10.020. [Epub ahead of print]

PMID:
30446464
4.

Nonlinear Kinetic Ion Response to Small Scale Magnetic Islands in Tokamak Plasmas: Neoclassical Tearing Mode Threshold Physics.

Imada K, Wilson HR, Connor JW, Dudkovskaia AV, Hill P.

Phys Rev Lett. 2018 Oct 26;121(17):175001. doi: 10.1103/PhysRevLett.121.175001.

PMID:
30411924
5.

Bone marrow infiltration of histiocytic sarcoma.

Mitani S, Kaneko H, Imada K.

Blood Res. 2018 Sep;53(3):185. doi: 10.5045/br.2018.53.3.185. Epub 2018 Sep 28. No abstract available.

6.

Involvement of Catechols in Acteoside in the Activation of Promatrix Metalloproteinase-2 and Membrane Type-1-Matrix Metalloproteinase Expression via a Phosphatidylinositol-3-Kinase Pathway in Human Dermal Fibroblasts.

Si N, Kanazawa H, Okuyama K, Imada K, Wang H, Yang J, Zhao H, Bian B, Ito A, Sato T.

Biol Pharm Bull. 2018;41(10):1530-1536. doi: 10.1248/bpb.b18-00107.

7.

Novel insight into an energy transduction mechanism of the bacterial flagellar type III protein export.

Terashima H, Imada K.

Biophys Physicobiol. 2018 Aug 22;15:173-178. doi: 10.2142/biophysico.15.0_173. eCollection 2018. Review.

8.

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone.

Akitake N, Shiota M, Obata H, Takeuchi A, Kashiwagi E, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.

Prostate Int. 2018 Sep;6(3):104-109. doi: 10.1016/j.prnil.2017.10.002. Epub 2017 Nov 21.

9.

Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer.

Shiota M, Kashiwagi E, Murakami T, Takeuchi A, Imada K, Inokuchi J, Tatsugami K, Eto M.

Andrologia. 2018 Dec;50(10):e13119. doi: 10.1111/and.13119. Epub 2018 Aug 7.

PMID:
30084497
10.

Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants.

Shiota M, Dejima T, Yamamoto Y, Takeuchi A, Imada K, Kashiwagi E, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Cancer Sci. 2018 Oct;109(10):3224-3234. doi: 10.1111/cas.13751. Epub 2018 Aug 28.

11.

In Vitro Reconstitution of Functional Type III Protein Export and Insights into Flagellar Assembly.

Terashima H, Kawamoto A, Tatsumi C, Namba K, Minamino T, Imada K.

MBio. 2018 Jun 26;9(3). pii: e00988-18. doi: 10.1128/mBio.00988-18.

12.

Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide.

Shiota M, Fujimoto N, Higashijima K, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Prostate. 2018 May 30. doi: 10.1002/pros.23661. [Epub ahead of print]

PMID:
29851126
13.

Insight into structural remodeling of the FlhA ring responsible for bacterial flagellar type III protein export.

Terahara N, Inoue Y, Kodera N, Morimoto YV, Uchihashi T, Imada K, Ando T, Namba K, Minamino T.

Sci Adv. 2018 Apr 25;4(4):eaao7054. doi: 10.1126/sciadv.aao7054. eCollection 2018 Apr.

14.

The Helix Rearrangement in the Periplasmic Domain of the Flagellar Stator B Subunit Activates Peptidoglycan Binding and Ion Influx.

Kojima S, Takao M, Almira G, Kawahara I, Sakuma M, Homma M, Kojima C, Imada K.

Structure. 2018 Apr 3;26(4):590-598.e5. doi: 10.1016/j.str.2018.02.016. Epub 2018 Mar 22.

PMID:
29576320
15.

[Autologous peripheral blood stem cell transplantation for treating primary central nervous system lymphoma: a single-center retrospective study].

Okubo Y, Kaneko H, Shimizu T, Nomura R, Hyuga M, Mitsuyoshi T, Tada K, Ukyo N, Mizutani C, Hatanaka K, Imada K.

Rinsho Ketsueki. 2018;59(1):33-39. doi: 10.11406/rinketsu.59.33. Japanese.

PMID:
29415935
16.

Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.

Ishida T, Jo T, Takemoto S, Suzushima H, Suehiro Y, Choi I, Yoshimitsu M, Saburi Y, Nosaka K, Utsunomiya A, Kobayashi Y, Yamamoto K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Imada K, Kato K, Moriuchi Y, Yoshimura K, Takahashi T, Tobinai K, Ueda R.

Br J Haematol. 2019 Feb;184(3):479-483. doi: 10.1111/bjh.15123. Epub 2018 Feb 7. No abstract available.

PMID:
29411857
17.

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1180-1186. doi: 10.1016/j.bbmt.2018.01.026. Epub 2018 Feb 1.

PMID:
29409882
18.

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.

Eso Y, Uza N, Yamagishi H, Imada K, Kimura Y, Masui T, Kodama Y, Seno H.

Medicine (Baltimore). 2017 Dec;96(50):e9217. doi: 10.1097/MD.0000000000009217.

19.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
20.

Structural differences in the bacterial flagellar motor among bacterial species.

Terashima H, Kawamoto A, Morimoto YV, Imada K, Minamino T.

Biophys Physicobiol. 2017 Dec 19;14:191-198. doi: 10.2142/biophysico.14.0_191. eCollection 2017. Review.

21.

Insight into adaptive remodeling of the rotor ring complex of the bacterial flagellar motor.

Kinoshita M, Furukawa Y, Uchiyama S, Imada K, Namba K, Minamino T.

Biochem Biophys Res Commun. 2018 Jan 29;496(1):12-17. doi: 10.1016/j.bbrc.2017.12.118. Epub 2017 Dec 30.

PMID:
29294326
22.

Bacterial flagellar axial structure and its construction.

Imada K.

Biophys Rev. 2018 Apr;10(2):559-570. doi: 10.1007/s12551-017-0378-z. Epub 2017 Dec 12. Review.

23.

Meiosis-specific localization of the exocytic Rab Ypt2 in fission yeast.

Imada K, Nakamura T.

Small GTPases. 2017 Sep 6:1-9. doi: 10.1080/21541248.2017.1356425. [Epub ahead of print]

PMID:
28876998
24.

Assembly and stoichiometry of the core structure of the bacterial flagellar type III export gate complex.

Fukumura T, Makino F, Dietsche T, Kinoshita M, Kato T, Wagner S, Namba K, Imada K, Minamino T.

PLoS Biol. 2017 Aug 3;15(8):e2002281. doi: 10.1371/journal.pbio.2002281. eCollection 2017 Aug.

25.

Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.

Narita T, Ishida T, Ito A, Masaki A, Kinoshita S, Suzuki S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Imada K, Tanaka Y, Takaori-Kondo A, Inagaki H, Scholz A, Lienau P, Kuroda T, Ueda R, Iida S.

Blood. 2017 Aug 31;130(9):1114-1124. doi: 10.1182/blood-2016-09-741983. Epub 2017 Jun 23.

26.

Design and Preparation of the Fragment Proteins of the Flagellar Components Suitable for X-Ray Crystal Structure Analysis.

Imada K.

Methods Mol Biol. 2017;1593:97-103. doi: 10.1007/978-1-4939-6927-2_7.

PMID:
28389947
27.

Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma.

Nishi K, Mitani S, Hatanaka K, Imada K.

Ann Hematol. 2017 Jun;96(6):1057-1058. doi: 10.1007/s00277-017-2977-y. Epub 2017 Mar 14. No abstract available.

PMID:
28293711
28.

Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD).

Shimizu T, Hatanaka K, Kaneko H, Shimada T, Imada K.

Int J Hematol. 2017 Jul;106(1):138-140. doi: 10.1007/s12185-017-2191-7. Epub 2017 Feb 7.

PMID:
28176228
29.

Socioeconomic, hygienic, and sanitation factors in reducing diarrhea in the Amazon.

Imada KS, Araújo TS, Muniz PT, Pádua VL.

Rev Saude Publica. 2016 Dec 22;50:77. doi: 10.1590/S1518-8787.2016050006505. English, Portuguese.

30.

Biochemical characterization of the flagellar stator-associated inner membrane protein FliL from Vibrio alginolyticus.

Kumar A, Isumi M, Sakuma M, Zhu S, Nishino Y, Onoue Y, Kojima S, Miyanoiri Y, Imada K, Homma M.

J Biochem. 2017 Apr 1;161(4):331-337. doi: 10.1093/jb/mvw076.

PMID:
28013221
31.

Rapidly progressive autoimmune pancytopenia successfully treated with steroids.

Mitani S, Okubo Y, Nishi K, Takahashi S, Tada K, Hatanaka K, Kaneko H, Ukyo N, Mizutani C, Imada K.

Rinsho Ketsueki. 2016;57(11):2324-2328. Japanese.

PMID:
27941280
32.
33.

Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Nationwide Survey by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Takagi S, Masuoka K, Uchida N, Kurokawa M, Nakamae H, Imada K, Iwato K, Ichinohe T, Atsuta Y, Takami A, Yano S.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2208-2213. doi: 10.1016/j.bbmt.2016.09.017. Epub 2016 Sep 22.

34.

Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.

Dejima T, Imada K, Takeuchi A, Shiota M, Leong J, Tombe T, Tam K, Fazli L, Naito S, Gleave ME, Ong CJ.

Prostate. 2017 Feb;77(3):309-320. doi: 10.1002/pros.23269. Epub 2016 Oct 24.

PMID:
27775154
35.

FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.

Imada K, Shiota M, Kuroiwa K, Sugimoto M, Abe T, Kohashi K, Yokomizo A, Eto M, Naito S, Oda Y.

Prostate. 2017 Feb;77(2):145-153. doi: 10.1002/pros.23254. Epub 2016 Oct 4.

PMID:
27699813
36.

Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma.

Konishi Y, Tada K, Nishi K, Imada K.

Ann Hematol. 2016 Oct;95(10):1739-40. doi: 10.1007/s00277-016-2762-3. Epub 2016 Jul 30. No abstract available.

PMID:
27473192
37.

Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2.

Yanatori I, Richardson DR, Imada K, Kishi F.

J Biol Chem. 2016 Aug 12;291(33):17303-18. doi: 10.1074/jbc.M116.721936. Epub 2016 Jun 14.

38.

Anti-arthritic actions of β-cryptoxanthin against the degradation of articular cartilage in vivo and in vitro.

Imada K, Tsuchida A, Ogawa K, Sofat N, Nagase H, Ito A, Sato T.

Biochem Biophys Res Commun. 2016 Aug 5;476(4):352-358. doi: 10.1016/j.bbrc.2016.05.126. Epub 2016 May 27.

PMID:
27240953
39.

Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy.

Miyakawa Y, Imada K, Ichinohe T, Nishio K, Abe T, Murata M, Ueda Y, Fujimura Y, Matsumoto M, Okamoto S.

Int J Hematol. 2016 Aug;104(2):228-35. doi: 10.1007/s12185-016-2019-x. Epub 2016 May 17.

PMID:
27188338
40.

Rearrangements of α-helical structures of FlgN chaperone control the binding affinity for its cognate substrates during flagellar type III export.

Kinoshita M, Nakanishi Y, Furukawa Y, Namba K, Imada K, Minamino T.

Mol Microbiol. 2016 Aug;101(4):656-70. doi: 10.1111/mmi.13415. Epub 2016 Jun 3.

41.

Plasmablastic lymphoma of the gallbladder.

Konishi Y, Kaneko H, Nishi K, Imada K.

Int J Hematol. 2016 Jul;104(1):1-3. doi: 10.1007/s12185-016-1999-x. Epub 2016 Apr 8. No abstract available.

PMID:
27059870
42.

Insight into the flagella type III export revealed by the complex structure of the type III ATPase and its regulator.

Imada K, Minamino T, Uchida Y, Kinoshita M, Namba K.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3633-8. doi: 10.1073/pnas.1524025113. Epub 2016 Mar 16.

43.

Dependence of fluorescent protein brightness on protein concentration in solution and enhancement of it.

Morikawa TJ, Fujita H, Kitamura A, Horio T, Yamamoto J, Kinjo M, Sasaki A, Machiyama H, Yoshizawa K, Ichimura T, Imada K, Nagai T, Watanabe TM.

Sci Rep. 2016 Mar 9;6:22342. doi: 10.1038/srep22342.

44.

Identification of a Vibrio cholerae chemoreceptor that senses taurine and amino acids as attractants.

Nishiyama S, Takahashi Y, Yamamoto K, Suzuki D, Itoh Y, Sumita K, Uchida Y, Homma M, Imada K, Kawagishi I.

Sci Rep. 2016 Feb 16;6:20866. doi: 10.1038/srep20866.

45.

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.

Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S, Iwato K, Nakaseko C, Kondo T, Imada K, Kimura F, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Taniguchi S, Fukuda T.

Leukemia. 2016 Aug;30(8):1742-5. doi: 10.1038/leu.2016.23. Epub 2016 Feb 12. No abstract available.

PMID:
26867671
46.

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.

Shiota M, Fujimoto N, Imada K, Yokomizo A, Itsumi M, Takeuchi A, Kuruma H, Inokuchi J, Tatsugami K, Uchiumi T, Oda Y, Naito S.

J Natl Cancer Inst. 2016 Feb 8;108(7). doi: 10.1093/jnci/djw005. Print 2016 Jul.

PMID:
26857528
47.

[Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].

Sasaki Y, Yonezawa A, Kinoshita Y, Kitagawa T, Mori M, Onaka T, Imada K.

Rinsho Ketsueki. 2015 Dec;56(12):2472-6. doi: 10.11406/rinketsu.56.2472. Japanese.

PMID:
26725358
48.

[Infliximab therapy for Crohn's-like gastrointestinal lesions after allogeneic bone marrow transplantation].

Onaka T, Kitagawa T, Mori M, Yonezawa A, Imada K.

Rinsho Ketsueki. 2015 Dec;56(12):2452-5. doi: 10.11406/rinketsu.56.2452. Japanese.

PMID:
26725354
49.

Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior.

Sugimoto M, Kohashi K, Kuroiwa K, Abe T, Yamada Y, Shiota M, Imada K, Naito S, Oda Y.

Virchows Arch. 2016 Mar;468(3):357-67. doi: 10.1007/s00428-015-1885-6. Epub 2015 Dec 9.

PMID:
26649732
50.

Epistasis effects of multiple ancestral-consensus amino acid substitutions on the thermal stability of glycerol kinase from Cellulomonas sp. NT3060.

Fukuda Y, Abe A, Tamura T, Kishimoto T, Sogabe A, Akanuma S, Yokobori S, Yamagishi A, Imada K, Inagaki K.

J Biosci Bioeng. 2016 May;121(5):497-502. doi: 10.1016/j.jbiosc.2015.09.011. Epub 2015 Oct 20.

PMID:
26493633

Supplemental Content

Support Center